March 14, 2017
Biocept, Catalyst Pharmaceuticals provide liquid biopsy testing for small cell lung cancer for patients with LEMS
Biocept and Catalyst Pharmaceuticals announced a partnership which will provide Biocept’s Target Selector platform to screen patients diagnosed with LEMS for early onset or recurrence of small cell lung cancer (SCLC).